Clinical Trial Update: Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 trial update of cellular immunotherapy targeting EBV in viral-induced cancers including various lymphomas; the study is terminated with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Lymphoma Large B-cell Diffuse
• Post-transplant Lymphoproliferative Disorder

Drugs mentioned

• Cell Medica cellular immunotherapy (EBV-targeted therapy)

Snippet

Sponsor: Cell Medica Ltd | Conditions: Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse | Phase 2 | Status: TERMINATED | Results posted: 2019-03-12